Results

Total Results: 428 records

Showing results for "grade d cancer".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol-amendment.pdf
    February 05, 2025 - cancersb Solid tumor cancers, including breast, prostate, testicular, cervical, and colon cancer. … D. … / or exp "Neoplasms, Germ Cell and Embryonal"/ or (hematologic cancer* or hematologic neoplasms or hematologic … Neoplasms/ or liver neoplasms/ or Prostatic Neoplasms/ or Testicular Neoplasms/ or Testicular Neoplasms … / or Uterine Cervical Neoplasms/ or ((cancer* or carcinoma?
  2. effectivehealthcare.ahrq.gov/sites/default/files/worker-health_executive.pdf
    April 01, 2016 - Sorensen G, McLellan D, Dennerlein JT, et al. … Cancer Causes Control. 2009 Aug;20(6):887-94. PMID: 19301135. 21. … Cancer Causes Control. 2007 Feb;18(1):51-9. PMID: 17186421. 28. … Schulz KF, Altman DG, Moher D, et al. … Atkins D, Chang SM, Gartlehner G, et al.
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-postpartum-screening_research-protocol.pdf
    May 01, 2013 - D. … screening, where the metric was colonoscopies per cancer death prevented, or in cervical cancer screening … , where the metric was colposcopies per cancer death prevented. … In these situations, a grade of insufficient will be assigned. … Moher D, Fortin P, Jadad AR, et al.
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
    March 01, 2022 - C-1 Appendix D. … D-1 Appendix E. … D-1 Appendix D. Literature Flow Diagram Figure D-1. … Takakuwa KM, Sulak D. … Medical cannabis or cannabinoids for chronic non- cancer and cancer related pain: a systematic review
  5. effectivehealthcare.ahrq.gov/sites/default/files/clinical-pathway-methods-report-appendix-k.pdf
    February 01, 2018 - • There is no evidence that supports the use of fidaxomicin in life-threatening CDI (D-III). … Magee G, Strauss ME, Thomas SM, Brown H, Baumer D, Broderick KC. … The University of Texas MD Anderson Cancer Center. … Houston (TX): The University of Texas MD Anderson Cancer Center; 2017. 10 p. … rating: GRADE system 5.
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
    August 01, 2017 - Qaseem A, Kansagara D, Forciea MA, et al. Ann Intern Med. 2016 Jul 19;165(2):125-33. … † The overall evidence grade was assessed based on the ratings for the following domains: study limitations … on the methodology used to assess strength of evidence, please refer to: Owens DK, Lohr KN, Atkins D, … Food and Drug Administration (FDA) for insomnia. d Other benzodiazepines include drugs approved by … �» Zolpidem: head injury or fracture requiring hospitalization, hip fracture, cancer �» Ramelteon
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_executive.pdf
    April 01, 2012 - Table D. … Table D. … total adverse events,100 incidence of headache,100 gastrointestinal discomfort,100 incidence of cancer … Garg RK, Nag D, Agrawal A. … Aruna D, Naidu MU.
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-infertility-evidence-summary.pdf
    May 01, 2019 - evidence on the outcome was too weak, sparse, or inconsistent to permit any conclusion to be drawn, a grade … • Women who undergo IVF demonstrated an increased risk of ovarian neoplasms and colorectal malignancies … ovarian tumors, and colorectal cancer No difference: IVF however was not associated with an increased … Sun X, Zhang D, Zhang W. … Effects of fertility drugs on cancers other than breast and gynecologic malignancies.
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharm-treatment-chronic-pain-protocol.pdf
    December 11, 2018 - D. … The strength of evidence will be assigned an overall grade of high, moderate, low, or insufficient … Boudreau D, Von Korff M, Rutter CM, et al. … Trends in long-term opioid therapy for chronic non-cancer pain. … Dowell D, Haegerich TM, Chou R.
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_executive.pdf
    April 01, 2012 - Oral DMARDs Anti-tumor necrosis factor drugs vs. … Those with high- risk comorbidities (cardiovascular events, diabetes, malignancies, renal impairment … evidence does not suggest an increased risk of severe adverse events, including cardiovascular or cancer … Most studies found no risk of cardiovascular events and malignancy with biologic DMARDs, except for … Owens DK, Lohr KN, Atkins D, et al.
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_research-protocol.pdf
    March 09, 2010 - Specifically, we will examine mortality, malignancy, serious infection, hepatitis, bone marrow suppression … D. … In these situations, a grade of “insufficient” will be assigned. … Myers E, McCrory D, Mills A, et al. Effectiveness of Assisted Reproductive Technology. … Outcomes, Timing, Settings RCTs Randomized Controlled Trials TEP Technical Expert Panel TNF Tumor
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
    March 01, 2012 - Quality (AHRQ) for its Effective Healthcare Program.20 This method is based on one developed by the Grade … Working Group,21 and classifies the grade of evidence according to the following criteria: High … The evidence grade is based on four primary domains (required) and four optional domains. … d. … D. Birnbaum, H. G. Oster, E. F. Lufkin, E. Mallet, D.
  13. effectivehealthcare.ahrq.gov/sites/default/files/cer-237-evidence-summary-palliative-care-ambulatory.pdf
    February 01, 2021 - ambulatory care for adults with serious life- threatening chronic illness and conditions other than cancer … Methods We completed a mixed-methods review focusing on serious chronic illnesses other than cancer … Waldfogel JM, Sloan DH, Cotter V, Hannum S, Heughan J, Chyr L, DeGroot L, Wilson R, Zhang A, Mahabare D,
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_executive.pdf
    February 01, 2014 - We used four domains to yield a final evidence grade: risk of bias, consistency, directness and precision … The final strength-of-evidence (SOE) grades were: (1) “high” grade (indicating high confidence that … outcomes—adherence, serious adverse events (as reported by investigators), withdrawal due to adverse events, cancer … final.cfm. 6 very unlikely to change our confidence in the estimate of the effect); (2) “moderate” grade … confidence in the estimate of the effect and is likely to change the estimate); and (4) “insufficient” grade
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-update_executive.pdf
    September 01, 2014 - included in the ECRI report stated that open surgical biopsy may miss one to two percent of breast cancers … Table D. … BMC Cancer. 2012;12:41. PMID: 22277164. 5. Bernardi D, Borsato G, Pellegrini M, et al. … Moher D, Liberati A, Tetzlaff J, et al. … Wells G, Shea B, O’Connell D, et al.
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/malnutrition-hospitalized-adults-protocol.pdf
    October 19, 2020 - can result from chronic starvation (e.g., anorexia nervosa); acute or chronic illness (e.g., certain cancers … Medicaid beneficiaries) • Patients with malignancy • Patients with gastrointestinal disease and subsequent … Studies of patients in specialty hospitals (e.g., psychiatric, ophthalmologic, orthopedic, cancer, … Owens D, Lohr K, Atkins D, et al. … The fate of abstracts submitted to a cancer meeting: factors which influence presentation and subsequent
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay_research-protocol.pdf
    May 02, 2011 - free survival, remission, and light chain escape Diagnostic accuracy for a) MGUS b) MM c) NSMM d) … will be retrieved from existing guidelines and narrative and systematic reviews and a search of other cancer-specific … D. … Grading the Evidence for Each Key Question We will follow the Methods Guide11 to grade the strength … Atkins D, Eccles M, Flottorp S, et al, for the GRADE Working Group.
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
    July 13, 2011 - or racial groups, and sex); Patients with medical comorbidities (e.g., ischemic heart disease, cancerD. … racial groups, and sex); Patients with medical comorbidities (e.g., ischemic heart disease, cancer … of evidence and the strength of recommendations I: Critical appraisal of existing approaches: The GRADE … Owens DK, Lohr KN, Atkins D, et al.
  19. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_executive.pdf
    January 01, 2006 - deaths due to NSAID-induced gastrointestinal complications, a higher death rate than that for cervical cancer … include long-term studies of these drugs for treating osteoarthritis or rheumatoid arthritis and for cancer … • Glucosamine and chondroitin • In one large, good-quality trial the combination of pharmaceutical-grade … • Most trials showing therapeutic benefits from glucosamine were conducted using pharmaceutical-grade … NSAIDs are needed, as these are likely to remain available even if the FDA approves pharmaceutical-grade
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/obesity-child_executive.pdf
    March 31, 2010 - hypertension; high cholesterol; stroke; heart disease; nonalcoholic fatty liver disease; certain cancers … Within this hierarchy, each study contributed only one weight-related measure to the grade. … We did not grade adverse events or clinical outcomes. … Owens DK, Lohr KN, Atkins D, et al. … Atkins D, Chang SM, Gartlehner G, et al.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: